The Forsyth Institute gets new CEO
August 31, 2017
. — An oral biologist takes the helm of The Forsyth Institute, a renowned dental and craniofacial research center, on Sept. 1.
Wenyuan Shi, Ph.D., will take the positions of chief executive officer and chief scientific officer of the institute and step down as chair of the section of oral biology at the University of California Los Angeles School of Dentistry and as the doctoral advisor for the oral biology Ph.D. program at the university, according to a news release.
Dr. Shi is credited as co-authoring more than 200 scientific articles and co-inventing 45 patents. He is also a co-founder of a biotechnology company, C3J Therapeutics, which aims to improve health through targeted, pathogen-specific antimicrobials to modulate microbiome, according to a news release.
"Dr. Shi's creativity, vision and drive will help reinvigorate Forsyth in a way that not only evokes our original mission of providing quality dental care to Boston's children but also takes Forsyth forward as the leader in cutting-edge dental research from the lab into the real world," said Peter Nessen, chair of the board of directors for the institute. "His track record as an innovator, entrepreneur and academic leader — paired with his extensive international network and proven ability to translate science into successful business — make Dr. Shi ideally suited to lead Forsyth into a bright future."
For more information about The Forsyth Institute, visit www.forsyth.org